Latest news from Baylor College of Medicine
Mouse models indicate burning more fat and less glucose could lead to diabetes Dec 19, 2016 While exercise endurance increases when muscles are made to burn more fat and less glucose, research shows this may lead to diabetes.
Quick test helps identify frailty in bedbound elderly Dec 15, 2016 For older adults who are hospitalized for ground-level falls, their level of frailty can be an important indicator of adverse health outcomes upon discharge.
For children with autism, the holidays take planning and communication Dec 15, 2016 Keys to success during the holiday season for families of children with autism spectrum disorder are advance communication and planning.
Adult children should pay closer attention to elderly parents during holiday visits Dec 14, 2016 The holidays are a practical time to check on mom and dad’s health and perhaps schedule much needed doctor appointments, according to Dr. Robert Roush, professor of medicine-geriatrics.
Dr. Matzuk elected to the National Academy of Inventors Dec 14, 2016 Dr. Martin M. Matzuk has been awarded the distinction of Fellow in the National Academy of Inventors for his contributions to reproductive medicine and therapeutics.
Safety precautions before you take the ice this winter Dec 13, 2016 Dr. Theodore Shybut shares ways to stay safe while enjoying ice skating during the holiday season.
Expert offers tips on coping with divorce during the holidays Dec 12, 2016 Dr. James Bray offers his tips on how to cope with divorce so families can enjoy the holidays.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapy Dec 9, 2016 A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer Dec 8, 2016 A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.
NSABP B52 trial shows estrogen deprivation in neoadjuvant chemotherapy breast cancer treatment is not antagonistic to pathologic complete response Dec 8, 2016 Research by Dr. Mothaffar F. Rimawi he finds that adding an aromatase inhibitor to presurgery breast cancer treatment did not significantly increase or decrease the percentage of patients who experienced a pathologic complete response.